Drugs / autologous dendritic cells electroporated with mRNA
autologous dendritic cells electroporated with mRNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00929019 | Jun 2009 → Apr 2016 | uveal melanoma | Radboud University Medical Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous dendritic cells electroporated with mRNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00929019 ↗ |
| Modality | Cell therapy | “Autologous mature monocyte-derived dendritic cells electroporated with mRNA” NCT00929019 ↗ |
| Route | Intravenous | “vaccinated intradermal/intravenously” NCT00929019 ↗ |